BL Pharmtech Corp. (KOSDAQ:065170)
South Korea
· Delayed Price · Currency is KRW 599.00
+9.00 (1.53%)
At close: Dec 5, 2025
BL Pharmtech Revenue
BL Pharmtech had revenue of 906.85M KRW in the quarter ending September 30, 2025, a decrease of -64.58%. This brings the company's revenue in the last twelve months to 6.98B, down -41.58% year-over-year. In the year 2024, BL Pharmtech had annual revenue of 8.81B, down -64.10%.
Revenue (ttm)
6.98B
Revenue Growth
-41.58%
P/S Ratio
2.29
Revenue / Employee
581.43M
Employees
12
Market Cap
15.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.81B | -15.72B | -64.10% |
| Dec 31, 2023 | 24.53B | 2.00B | 8.89% |
| Dec 31, 2022 | 22.52B | -61.92B | -73.33% |
| Dec 31, 2021 | 84.44B | 18.75B | 28.54% |
| Dec 31, 2020 | 65.69B | 6.82B | 11.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |